NorthWest Biotherapeutics Inc (NWBO)

[beachhyena]

What would be interesting to find out is if there are still patients being treated at the Fraunhofer facility in Leipzig, Germany with DCVAX-L. This would tell us a great deal.

Exemption in Germany from a 2014 PR on NWBO's website.
"Patients with recurrent GBM and patients with other glioma brain cancers are not eligible for the Phase III clinical trial, but all such patients are eligible for treatment under the DCVax-L Hospital Exemption.

The first DCVax-L Hospital Exemption patient underwent surgery to remove his GBM tumor last week, and the manufacturing of his DCVax-L also began last week with the processing of his tumor tissue at the Fraunhofer facility in Leipzig, Germany.